Skip to content

Insider · CIK 0001970526

Andrew Lauck

director

Files at SRTA (Strata Critical Medical, Inc.). First filing Dec 5, 2025, latest Dec 5, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$22k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

SRTA: Strata Critical Medical, Inc.

SRTAOct 9, 2026 · close 4.53

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
27Weak
SRTAbuy 2
Strata Critical Medical, Inc.
$22k
5,000 shares
+4%+73% from low-26% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Dec 5, 2025SRTA
Strata Critical Medical, Inc.
POpen-market purchase
Class A common stock, $0.0001 par value per share
+5,000$4.37$22k135,642Dec 5, 2025
Aug 29, 2025SRTA
Strata Critical Medical, Inc.
AGrant or award
Class A common stock, $0.0001 par value per share
+11,844$0.00$0130,642Sep 3, 2025
Aug 1, 2025SRTA
Strata Critical Medical, Inc.
AGrant or award
Class A common stock, $0.0001 par value per share
+35,534$0.00$0118,798Aug 5, 2025
May 6, 2025SRTA
Strata Critical Medical, Inc.
AGrant or award
Class A common stock, $0.0001 par value per share
+56,135$0.00$056,135May 7, 2025
May 6, 2025SRTA
Strata Critical Medical, Inc.
AGrant or award
Class A common stock, $0.0001 par value per share
+27,129$0.00$083,264May 7, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Andrew Lauck: insider trades and track record | InsiderTell